Skip to main content
PMC home page
Cancer Immunology, Immunotherapy : CII logoLink to Cancer Immunology, Immunotherapy : CII
. 1986 Apr;21(3):174–182. doi: 10.1007/BF00199358

Effects of inflammation products on immune systems

Lysophosphatidylcholine stimulates macrophages

Benjamim Z Ngwenya 1,✉, Nobuto Yamamoto 1
PMCID: PMC11038332  PMID: 2938735

Abstract

Microbial infection causes inflammation which stimulates macrophage functions. One of the inflammatory products, lysophosphatidylcholine (lyso-Pc), can stimulate macrophage activities. Treatment of mice with lyso-Pc enhanced spreading and ingestion activities of peritoneal macrophages. In vitro treatment of macrophages with lyso-Pc greatly enhanced spreading but not ingestion activities. However, incubation of a mixture of adherent and nonadherent cells with lyso-Pc produced a markedly enhanced ingestion activity of macrophages, implying the contribution of nonadherent cells to the stimulation of macrophages. Time course studies of the stimulation of these macrophages showed that spreading activity is stimulated immediately, even 30 min, after their contact with lyso-Pc while induction of ingestion activity requires a latent period of about 5 h. When the specificity of the macrophage receptors for ingestion was analyzed using defined immunoglobulins (i.e., IgG and IgM) with or without complement, lyso-Pc-activated macrophages efficiently ingested IgG-coated sheep erythrocytes independent of complement. However, macrophages of the same lyso-Pc-treated mice did not ingest erythrocytes coated with IgM and complement. These observations suggest that lyso-Pc-stimulated macrophages ingest the targets via Fc-receptors but not C3b receptors.

Keywords: Immune System, Cancer Research, Latent Period, Peritoneal Macrophage, Macrophage Activity

References

  • 1.Andreesen R, Modolell M, Weltizien HU, Eibl H, Common HH, Lohr GW, Munder PG. Selective destruction of human leukemic cells by alkyl lysophospholipids. Cancer Res. 1978;38:3894. [PubMed] [Google Scholar]
  • 2.Berdel WE, Fink U, Egger B, Reichert A, Munder PG, Rastetter J. Inhibition by alkyl-lysophospholipids of tritiated thymidine uptake in cells of human malignant urologic tumors. J Natl Cancer Inst. 1981;66:813. [PubMed] [Google Scholar]
  • 3.Berdel WE, Greiner E, Fink M, Stavrou D, Reichert A, Rastetter J, Snyder F (1982) Cytotoxic effect of alkyl-lysophospholipids (ALP) in rat brain tumor cells. Proc Am Soc Cancer Res p 198 No. 782
  • 4.Berdel WE, Fink U, Rastetter J (1982) Phase I study of alkyl-lysophospholipids (ALP) in advanced malignant disease. Proc Am Soc Clin Oncol p 18, No C71
  • 5.Bianco C, Griffin FM, Silverstein SC. Studies of macrophage complement receptors. Alteration of receptor function upon macrophage activation. J Exp Med. 1975;141:1278. doi: 10.1084/jem.141.6.1278. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Bianco C, Eden AA, Cohn AZ. The induction of macrophage spreading: role of coagulation factors and the complement system. J Exp Med. 1976;144:1531. doi: 10.1084/jem.144.6.1531. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Chien KR, Abrams J, Serioni A, Martin JT, Farber JL. Accelerated phospholipid degradation and associated membrane dysfunction in irreversible ischemic liver cell inury. J Biol Chem. 1978;253:4809. [PubMed] [Google Scholar]
  • 8.Chon ZA, Benson B. The differentiation of mononuclear phagocytes, morphology, cytochemistry, and biochemistry. J Exp med. 1975;121:153. doi: 10.1084/jem.121.1.153. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Davidson I, Nelson DA. The blood. In: Davidson I, Henry JB, editors. Todd-Sanford Clinical diagnosis by laboratory methods. 14th edn. Philadelphia: W. B. Sauners Company; 1969. p. 120. [Google Scholar]
  • 10.Doe WF, Henson PM. Macrophage stimulation by bacterial lipopolysaccharides. I. Cytolytic effect on tumor target cells. J Exp Med. 1978;148:544. doi: 10.1084/jem.148.2.544. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Elin RJ, Wolff SM, Cheolid L. Non-specific resistance to infection induced in mice by a water soluble adjuvant derived from Mycobacterium smegmatis . J Infect Dis. 1976;133:500. doi: 10.1093/infdis/133.5.500. [DOI] [PubMed] [Google Scholar]
  • 12.Gillett MPT, Besterman EMM. Plasma concentration of lysolecithin and other phospholipids in the healthy population and in men suffering from atherosclerosis diseases. Atherosclerosis. 1975;22:111. doi: 10.1016/0021-9150(75)90072-6. [DOI] [PubMed] [Google Scholar]
  • 13.Goerke J, deGier J, Bensen PPM. Silica gel stimulates the hydrolysis of lecithin by phospholipase A. Biochim Biophys Acta. 1971;248:245. doi: 10.1016/0005-2760(71)90012-9. [DOI] [PubMed] [Google Scholar]
  • 14.Griffin FM, Silverstein SC. Segmental response of the macrophages plasma membrane to a phagocytic stimulus. J Exp Med. 1974;139:323. doi: 10.1084/jem.139.2.323. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Hoerni B, Durand M, Richard P, deMascarel A, Hoerni-Simon G, Chauvegne J, Lagarde C. Successful maintenance immunotherapy by BCG of non-Hidgkin's Malignant lymphomas: Results of controlled trail. Br J Haematol. 1979;42:507. doi: 10.1111/j.1365-2141.1979.tb01163.x. [DOI] [PubMed] [Google Scholar]
  • 16.Hoerni B, Durand M, Eghbali H, Hoerni-simon G, Richard P, deMascarel A. Maintenance immunotherapy with BCG in non-Hodgkin's malignant lymphomas: A progress report of a randomized trial. In: Mathe G, Bonadonna G, Salmon S, editors. Adjuvant therapies of cancer. Berlin, Heidelberg, New York: Springer-Verlag; 1982. p. 92. [Google Scholar]
  • 17.Le Mevel BP. Ewing's Sarcoma: 5 year survival under adjuvant chemotherapy. In: Mathe G, Bonadonna G, Salmon S, editors. Adjuvant therapies of cancer. Berlin, Heidelberg, New York: Springer-Verlag; 1982. p. 128. [DOI] [PubMed] [Google Scholar]
  • 18.Lowe J, Shore DF, Iles PB, Langman MJS, Baldwin RW. Intrapleural BCG in operable lung cancer. Lancet. 1980;I:11. doi: 10.1016/s0140-6736(80)90551-6. [DOI] [PubMed] [Google Scholar]
  • 19.Mantovani B, Robinovitch M, Nussenszweig V. Phagocytosis of murine complexes by macrophages. Different roles of the macrophage receptor sites for complement (C3) and for immunoglobulin (IgG) J Exp Med. 1972;135:780. doi: 10.1084/jem.135.4.780. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.McKneally MF, Maver C, Kausel HW. Regional immunotherapy of lung cancer with intrapleural BCG. Lancet. 1976;I:377. doi: 10.1016/S0140-6736(76)90212-9. [DOI] [PubMed] [Google Scholar]
  • 21.Modell M, Munder PG. The action of purified phospholipase B in inflammation and immunity. Int Arch Allergy. 1972;43:724. doi: 10.1159/000230888. [DOI] [PubMed] [Google Scholar]
  • 22.Munder PG, Modelell M, Ferber E, Fischer H. The relationship between macrophages and adjuvants activity. In: Furth R, editor. Mononuclear phagocytes. Oxford: Blackwell Scientific Publications; 1970. p. 445. [Google Scholar]
  • 23.Munder PG, Fischer H, Weltzien HU, Oettgen HW, Westphal O. Lysolecithin analogs: a new class of immunopotentiators with antitumor activity. Proc Am Assoc Cancer Res. 1976;17:174. [Google Scholar]
  • 24.Munder PG, Modelell M, Andreesen R, Weltzien HU, Westphal O. Lysophosphatidylcholine (Lysolecithin) and its synthetic analogs, immunomodulating and other biological effects. In: Chedid L, Miescher PA, Mueller-Eberhard HJ, editors. Immunomodulating: Springer Semin Immunopath Vol 2 No 1–2. Berlin: Springer-Verlag; 1980. p. 177. [Google Scholar]
  • 25.Neumann C, Sorg C. Sequential expression of functions during macrophage differentiation in murine bone marrow liquid cultures. Eur J Immunol. 1980;10:834. doi: 10.1002/eji.1830101107. [DOI] [PubMed] [Google Scholar]
  • 26.Newman SL, Musson RA, Henson PM. Development of functional complement receptors during in vitro maturation of human monocytes into macrophages. J Immunol. 1980;125:2236. [PubMed] [Google Scholar]
  • 27.Ngwenya BZ, Yamamoto N. Activation of peritoneal macrophages by lysophosphatidylcholine. Biochim Biophys Acta. 1985;839:9. doi: 10.1016/0304-4165(85)90175-8. [DOI] [PubMed] [Google Scholar]
  • 28.Ottolenghi A, Kocan AA, Weatherly NF, Larsh JE. Nipposdtrongylus brasiliensis: Phospholipase in nonsensitized and sensitized rats after challenge. Exp Parasitol. 1975;38:96. doi: 10.1016/0014-4894(75)90042-9. [DOI] [PubMed] [Google Scholar]
  • 29.Rapp HJ, Prier JE. Immunotherapy of experimental cancer with BCG. In: Crowell RL, Friedman H, editors. Tumor virus infections and immunity. Baltimore: University Park Press; 1976. p. 261. [Google Scholar]
  • 30.Runge MH, Andreesen R, Pfleideres A, Munder PG. Destruction of human solid tumors by alkyl-lysophospholipids. J Natl Cancer Inst. 1980;64:1301. doi: 10.1093/jnci/64.6.1301. [DOI] [PubMed] [Google Scholar]
  • 31.Saluk PH, Edmundowicz S, Wrighley DM, Tabor DR. Co-expression of enhanced spreading, ingestion, and inhibition of tumor cell proliferation by macrophages from lipopolysaccharide injected mice. Cancer Immunol Immunother. 1981;11:159. [Google Scholar]
  • 32.Senn HJ, Amgwerd R, Jungi WF, Hochuli R, Ammann J, Engelhart G, Heinz C, Wick A, Enderlin F, Greux G, Simon B, Lanz R, Bigler R, Seiler S. Adjuvant chemoimmunotherapy with LMF plus BCG in node-negative and node-positive breast cancer-intermediate report at 4 years. In: Mathe G, Bonadonna G, Salmon S, editors. Adjuvant therapies of cancer. Berlin, Heidelberg, New York: Springer-Verlag; 1982. p. 177. [DOI] [PubMed] [Google Scholar]
  • 33.Snyder F, Maline B, Piantodosi C. Tetrahydropteridine-dependent cleavage enzyme for O-alkyl-lipids: substrate specificity. Biochim Biophys Acta. 1973;316:259. doi: 10.1016/0005-2760(73)90018-0. [DOI] [PubMed] [Google Scholar]
  • 34.Soodsma JF, Piantodosi C, Snyder F. The biocleavage of aklyl-glyceryl ethers in Morris hepatomas and other transplantable neoplasms. Cancer Res. 1970;30:309. [PubMed] [Google Scholar]
  • 35.Tabor DR, Saluk PH. The functional heterogenecity of murine-resident macrophages to a chemotactic signal and induction of C3b receptor-mediated ingestion. Immunol Lett. 1981;3:371. doi: 10.1016/0165-2478(81)90069-9. [DOI] [PubMed] [Google Scholar]
  • 36.White RG, Coons HH, Connally JM. Studies on antibody production III. The alum granuloma. J Exp Med. 1955;102:73. doi: 10.1084/jem.102.1.73. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Wrigley DM, Saluk PH. Induction of C3b-mediated phagocytosis in macrophages by distinct populations of lipopolysaccharide-stimulated lymphocytes. Infect, Immun. 1981;34:780. doi: 10.1128/iai.34.3.780-786.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Yamamoto N, Kawada K, Ochiai H, Droffner ML, Ngwenya BZ (1983) Activation of macrophages by lysophosphatidylcholine and their analogs. Abst Am Soc Microbiol, p 25

Articles from Cancer Immunology, Immunotherapy : CII are provided here courtesy of Springer

RESOURCES